Child Health

Our Unit works with clinicians and other researchers on a broad range of child health themes.

Overview

The Health Economics Unit works with the clinicians and researchers from the Royal Children’s Hospital (RCH) and the Murdoch Children’s Research Institute (MCRI) on a broad range of healthcare themes. Some of the current collaborations take place with the Cardiology Department, the Department of Neurology, Centre for Community Child Health, Emergency Department and Health Services Research Unit in RCH and MCRI and involve the studies of the healthcare needs of children born with single ventricles, the cost-effectiveness of decision rules for head injuries, infant immune health, patterns of contact with emergency department, and how children use health services in general.

Projects

Optimising Early Respiratory Support for Preterm Infants: The HIPSTER Trial

Incorporating budget impact within cost-effectiveness analysis

VITALITY trial: the role of postnatal vitamin D supplementation in infant immune health

Fontan children: healthcare needs for children with single ventricles

Healthcare services utilization for Australian children: how children use health services and the associated costs

APHIRST study: the cost effectiveness of decision rules for head injuries in children

Income inequality in how children use health services

Economic evaluation of surfactant treatment for newborns with respiratory distress syndrome in Fiji

Selected Publications

Allen, KJ., Panjari, M., Koplin, JJ., Ponsonby, AL., Vuillermin, P., Gurrin, LC., Greaves, R., CARVALHO, N., DALZIEL, K., Tang, MLK., Lee, KJ., Wake, M., Curtis, N., & Dharmage, SC. (2015). VITALITY trial: protocol for a randomised controlled trial to establish the role of postnatal vitamin D supplementation in infant immune health. BMJ Open, 5(12).

Wilson, TG., Iyengar, AJ., Winlaw, DS., Weintraub, RG., Wheaton, GR., Gentles, TL., Ayer, J., Grigg, LE., Justo, RN., Radford, DJ., Bullock, A., Celermajer, DS., DALZIEL, K., SCHILLING, C., & d'Udekem, Y. (2016). Use of ACE inhibitors in Fontan: Rational or irrational? International Journal of Cardiology, 210, 95-99.

SCHILLING, C., DALZIEL, K., Nunn, R., Du Plessis, K., Shi, W. Y., Celermajer, D., Winlaw, D., Weintraub, RG., Grigg, L., Radford, RJ., Bullock, A., Gentles, TL., Wheaton, GR., Hornung, T., Justo, RN., &  d'Udekem, Y. (2016). The Fontan epidemic: Population projections from the Australia and New Zealand Fontan Registry. International Journal of Cardiology, 219, 14-19.

Funding

Giving an Adult Life after Fontan Surgery to Those with the Most Severe Congenital Heart Conditions (Partnership Projects)